Ascendis Pharma As Stock Analysis

Ascendis Stock Analysis Notes

About 99.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 7.86. Ascendis Pharma AS had not issued any dividends in recent years. Ascendis Pharma AS, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark. Ascendis Pharma is traded on NASDAQ Exchange in the United States. For more info on Ascendis Pharma AS please contact Jan Mikkelsen at 45 70 22 22 44 or go to https://ascendispharma.com.

Ascendis Pharma AS Investment Alerts

Ascendis Pharma AS Upcoming and Recent Events

Ascendis Largest EPS Surprises

View All Earnings Estimates

Ascendis Pharma Environmental, Social, and Governance (ESG) Scores

Ascendis Stock Institutional Investors

Note, although Ascendis Pharma's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Ascendis Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.33 B.

Ascendis Profitablity

The company has Profit Margin (PM) of (1.54) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (3.7) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $3.7.

Management Efficiency

Ascendis Pharma AS has return on total asset (ROA) of (0.2792) % which means that it has lost $0.2792 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (8.1843) %, meaning that it created substantial loss on money invested by shareholders. Ascendis Pharma's management efficiency ratios could be used to measure how well Ascendis Pharma manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 3.47, whereas Return On Tangible Assets are forecasted to decline to (0.62). At present, Ascendis Pharma's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 374.1 M, whereas Non Current Assets Total are forecasted to decline to about 79.4 M.

Technical Drivers

As of the 22nd of November, Ascendis Pharma shows the mean deviation of 1.98, and Risk Adjusted Performance of (0.02). Ascendis Pharma AS technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Ascendis Pharma AS standard deviation, as well as the relationship between the maximum drawdown and kurtosis to decide if Ascendis Pharma AS is priced correctly, providing market reflects its regular price of 129.81 per share. Given that Ascendis Pharma has information ratio of (0.07), we suggest you to validate Ascendis Pharma AS's prevailing market performance to make sure the company can sustain itself at a future point.

Ascendis Pharma AS Price Movement Analysis

Ascendis Pharma Outstanding Bonds

Ascendis Pharma Predictive Daily Indicators

Ascendis Pharma Corporate Filings

Ascendis Pharma Forecast Models

Ascendis Pharma's time-series forecasting models are one of many Ascendis Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ascendis Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ascendis Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ascendis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Ascendis Pharma. By using and applying Ascendis Stock analysis, traders can create a robust methodology for identifying Ascendis entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ascendis analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ascendis analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Ascendis Pharma AS stock analysis indicators help investors evaluate how Ascendis Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Ascendis Pharma shares will generate the highest return on investment. By understating and applying Ascendis Pharma stock analysis, traders can identify Ascendis Pharma position entry and exit signals to maximize returns.

When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.